amino phyl line in table format

Upload: jean-de-vera-melendez

Post on 04-Apr-2018

220 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/29/2019 Amino Phyl Line in Table Format

    1/2

    DRUG STUDY

    Drug Name Dosages Therapeutic

    Actions

    Indications Adverse effects Contraindications Nursing considerations

    aminophylline

    (theophylline

    ethylenediami

    ne)

    (am in off' i lin)

    Truphylline

    Pregnancy

    Category C

    Drug classes

    Bronchodilator

    Xanthine

    Individualize dosage: Baseadjustments on clinical responses;

    monitor serum theophylline levels;

    maintain therapeutic range of 10

    20 mcg/mL; base dosage on lean

    body mass; 127 mg aminophylline

    dihydrate = 100 mg theophyllineanhydrous.

    ADULTS

    Oral

    Acute symptoms requiring rapidtheophyllinization in patients not

    receiving theophylline: An initial

    loading dose is required, as

    indicated below:

    PatientGroup

    Loading

    Followedby

    Maintenance

    Youngadultsmokers

    7.6mg/kg

    3.8mg/kg q4 hr 3doses

    3.8mg/kg q6 hr

    Adultnonsmokers

    who areotherwisehealthy

    7.6

    mg/kg

    3.8mg/kg q6 hr 2

    doses

    3.8

    mg/kg q8 hr

    *Expressed as aminophylline

    Long-term therapy: Usual range is6001,600 mg/day PO in three to

    four divided doses.

    Rectal

    500 mg q 68 hr by rectalsuppository or retention enema.

    PEDIATRIC PATIENTS

    Children are very sensitive to CNS

    stimulant action of theophylline; use

    caution in younger children unable to

    complain of minor side effects.

    < 6 mo: Not recommended. < 6 yr: Use of timed-release

    products not recommended.

    Oral

    Relaxes bronchial

    smooth muscle,

    causing

    bronchodilation

    and increasing

    vital capacity,

    which has been

    impaired by

    bronchospasm

    and air trapping;

    in higherconcentrations, it

    also inhibits the

    release of slow-

    reacting

    substance of

    anaphylaxis (SRS-

    A) and histamine.

    Symptomatic reliefor prevention of

    bronchial asthma

    and reversible

    bronchospasm

    associated with

    chronic bronchitis

    and emphysema

    Unlabeled uses:Respiratory

    stimulant inCheyne-Stokes

    respiration;

    treatment of

    apnea and

    bradycardia in

    premature babies

    Serum theophylline levels 2025 mcg/mL: Nausea,

    vomiting, diarrhea,

    headache, insomnia,

    irritability (75% of patients)

    Serum theophylline levels >3035 mcg/mL:

    Hyperglycemia,hypotension, cardiac

    arrhythmias, seizures,

    tachycardia (> 10 mcg/mL

    in premature newborns);

    brain damage

    CNS: Irritability (especiallychildren); restlessness,

    dizziness, muscle twitching,

    seizures, severe depression,

    stammering speech;

    abnormal behavior

    characterized by

    withdrawal, mutism, and

    unresponsiveness

    alternating with

    hyperactive periods

    CV: Palpitations, sinustachycardia, ventricular

    tachycardia, life-

    threatening ventricular

    arrhythmias, circulatory

    failure

    GI: Loss of appetite,hematemesis, epigastric

    pain, gastroesophageal

    reflux during sleep,

    increased AST

    GU: Proteinuria, increasedexcretion of renal tubular

    cells and RBCs; diuresis

    (dehydration), urinary

    retention in men with

    prostate enlargement

    Respiratory: Tachypnea,respiratory arrest

    Other: Fever, flushing,hyperglycemia, SIADH, rash

    Contraindicated withhypersensitivity to any xanthine or

    to ethylenediamine, peptic ulcer,

    active gastritis; rectal or colonic

    irritation or infection (use rectal

    preparations).

    Use cautiously with cardiacarrhythmias, acute myocardial

    injury, CHF, cor pulmonale, severe

    hypertension, severe hypoxemia,

    renal or hepatic disease,hyperthyroidism, alcoholism, labor,

    lactation, pregnancy.

    Assessment

    History: Hypersensitivity to any xanthine or toethylenediamine, peptic ulcer, active gastritis

    arrhythmias, acute myocardial injury, CHF, co

    pulmonale, severe hypertension, severe hypo

    renal or hepatic disease, hyperthyroidism, alc

    labor, lactation, rectal or colonic irritation or in

    (aminophylline rectal preparations)

    Physical: Bowel sounds, normal output; P, auscBP, perfusion, ECG; R, adventitious sounds; freof urination, voiding, normal output pattern, u

    LFTs, renal function tests; l iver palpation; thyro

    function tests; skin color, texture, lesions; reflex

    bilateral grip strength, affect, EEG

    Interventions

    Administer to pregnant patients only when cleneededneonatal tachycardia, jitteriness, an

    withdrawal apnea observed when mothers re

    xanthines up until delivery.

    Caution patient not to chew or crush enteric-timed-release forms.

    Give immediate-release, liquid dosage forms wif GI effects occur.

    Do not give timed-release forms with food; thebe given on an empty stomach 1 hr before ormeals.

    Maintain adequate hydration. Monitor results of serum theophylline levels ca

    and arrange for reduced dosage if serum leve

    exceed therapeutic range of 1020 mcg/mL.

    Take serum samples to determine peak theopconcentration drawn 1530 min after an IV loa

    dose.

    Monitor for clinical signs of adverse effects, paif serum theophylline levels are not available.

    Ensure that diazepam is readily available to trseizures.

    Teaching points

    Take this drug exactly as prescribed; if a timedproduct is prescribed, take this drug on an emstomach, 1 hour before or 2 hours after meals

    Do not to chew or crush timed-release prepar Administer rectal solution or suppositories afte

    emptying the rectum.

    It may be necessary to take this drug around-for adequate control of asthma attacks.

    Avoid excessive intake of coffee, tea, cocoa,beverages, and chocolate.

  • 7/29/2019 Amino Phyl Line in Table Format

    2/2

    DRUG STUDY

    Acute therapy: For acutesymptoms requiring rapid

    theophyllinization in patients

    not receiving theophylline, a

    loading dose is required.

    Recommendations are as

    follows:

    PatientGroup

    LoadingFollowedby

    Maintenance

    Children 6mo9 yr

    7.6mg/kg

    5.1 mg/kgq 4 hr 3

    doses

    5.1 mg/kg q6 hr

    Children916 yr

    7.6mg/kg

    3.8 mg/kgq 4 hr 3doses

    3.8 mg/kg q6 hr

    Long-term therapy: 20.3 mg/kgor 508 mg/day (immediate-

    release) or 15.2 mg/kg or 508

    mg/day (extended-release)

    PO; slow clinical adjustment of

    the oral preparations is

    preferred; monitor clinical

    response and serum

    theophylline levels. In the

    absence of serum levels, adjust

    up to the maximum dosage

    shown below, providing the

    dosage is tolerated.

    Age Maximum Daily Dose

    < 9 yr 30.4 mg/kg/day

    912 yr 25.3 mg/kg/day

    1216 yr 22.8 mg/kg/day

    > 16 yr16.5 mg/kg/day or

    1,100 mg, whichever isless

    *Expressed as aminophylline

    Smoking cigarettes or other tobacco productthe drug's effectiveness. Try not to smoke. Not

    health care provider if smoking habits change

    taking this drug.

    Frequent blood tests may be necessary to moeffect of this drug and to ensure safe and effe

    dosage; keep all appointments for blood tests

    other monitoring.

    You may experience these side effects: Nauseappetite (taking this drug with food may help

    the immediate-release or li quid dosage forms

    difficulty sleeping, depression, emotional labili

    (reversible). Report nausea, vomiting, severe GI pain, restle

    seizures, irregular heartbeat.